Jing Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jing Guo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Biao Cheng
Department of Gerontology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan, 610072, China
1 shared publication - Georgi Z. Genchev
Center for Biomedical Informatics, Shanghai Children's Hospital, Shanghai, China
1 shared publication - Guoli Tian
Newborn Screening Center, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication - Hui Lu
State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China
1 shared publication - Jianlei Gu
Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut
1 shared publication - Minghuan Fu
Department of Gerontology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan, 610072, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 23 September 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 8, 189503-189512
Enhanced Deep Learning Assisted Convolutional Neural Network for Heart Disease Prediction on the Internet of Medical Things Platform
The diagnosis of heart disease has become a difficult medical task in the present medical research. This diagnosis depends on the detailed and precise analysis of the patient’s clinical test data on an individual’s health history. The enormous developments in the field of deep learning seek to create intelligent automated systems that help doctors both to predict and to determine the disease with the internet of things (IoT) assistance. Therefore, the Enhanced Deep learning assisted Convolutional Neural Network (EDCNN) has been proposed to assist and improve patient prognostics of heart disease. The EDCNN model is focused on a deeper architecture which covers multi-layer perceptron’s model with regularization learning approaches. Furthermore, the system performance is validated with full features and minimized features. Hence, the reduction in the features affects the efficiency of classifiers in terms of processing time, and accuracy has been mathematically analyzed with test results. The EDCNN system has been implemented on the Internet of Medical Things Platform (IoMT) for decision support systems which helps doctors to effectively diagnose heart patient’s information in cloud platforms anywhere in the world. The test results show compared to conventional approaches such as Artificial Neural Network (ANN), Deep Neural Network (DNN), Ensemble Deep Learning-based smart healthcare system (EDL-SHS), Recurrent neural network (RNN), Neural network ensemble method (NNE), based on the analysis the designed diagnostic system can efficiently determine the risk level of heart disease effectively. Test results show that a flexible design and subsequent tuning of EDCNN hyperparameters can achieve a precision of up to 99.1 %.
- 23 September 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 8, 189503-189512
Top Cited PapersOpen AccessEnhanced Deep Learning Assisted Convolutional Neural Network for Heart Disease Prediction on the Internet of Medical Things Platform
The diagnosis of heart disease has become a difficult medical task in the present medical research. This diagnosis depends on the detailed and precise analysis of the patient’s clinical test data on an individual’s health history. The enormous developments in the field of deep learning seek to create intelligent automated systems that help doctors both to predict and to determine the disease with the internet of things (IoT) assistance. Therefore, the Enhanced Deep learning assisted Convolutional Neural Network (EDCNN) has been proposed to assist and improve patient prognostics of heart disease. The EDCNN model is focused on a deeper architecture which covers multi-layer perceptron’s model with regularization learning approaches. Furthermore, the system performance is validated with full features and minimized features. Hence, the reduction in the features affects the efficiency of classifiers in terms of processing time, and accuracy has been mathematically analyzed with test results. The EDCNN system has been implemented on the Internet of Medical Things Platform (IoMT) for decision support systems which helps doctors to effectively diagnose heart patient’s information in cloud platforms anywhere in the world. The test results show compared to conventional approaches such as Artificial Neural Network (ANN), Deep Neural Network (DNN), Ensemble Deep Learning-based smart healthcare system (EDL-SHS), Recurrent neural network (RNN), Neural network ensemble method (NNE), based on the analysis the designed diagnostic system can efficiently determine the risk level of heart disease effectively. Test results show that a flexible design and subsequent tuning of EDCNN hyperparameters can achieve a precision of up to 99.1 %.
- Open Access
- 7 July 2020
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 7, 115
Improving the Diagnosis of Phenylketonuria by Using a Machine Learning–Based Screening Model of Neonatal MRM Data
Phenylketonuria (PKU) is a common genetic metabolic disorder that affects the infant's nerve development and manifests as abnormal behavior and developmental delay as the child grows. Currently, a triple–quadrupole mass spectrometer (TQ-MS) is a common high-accuracy clinical PKU screening method. However, there is high false-positive rate associated with this modality, and its reduction can provide a diagnostic and economic benefit to both pediatric patients and health providers. Machine learning methods have the advantage of utilizing high-dimensional and complex features, which can be obtained from the patient's metabolic patterns and interrogated for clinically relevant knowledge. In this study, using TQ-MS screening data of more than 600,000 patients collected at the Newborn Screening Center of Shanghai Children's Hospital, we derived a dataset containing 256 PKU-suspected cases. We then developed a machine learning logistic regression analysis model with the aim to minimize false-positive rates in the results of the initial PKU test. The model attained a 95–100% sensitivity, the specificity was improved 53.14%, and positive predictive value increased from 19.14 to 32.16%. Our study shows that machine learning models may be used as a pediatric diagnosis aid tool to reduce the number of suspected cases and to help eliminate patient recall. Our study can serve as a future reference for the selection and evaluation of computational screening methods.
- 7 July 2020
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 7, 115
Open AccessImproving the Diagnosis of Phenylketonuria by Using a Machine Learning–Based Screening Model of Neonatal MRM Data
Phenylketonuria (PKU) is a common genetic metabolic disorder that affects the infant's nerve development and manifests as abnormal behavior and developmental delay as the child grows. Currently, a triple–quadrupole mass spectrometer (TQ-MS) is a common high-accuracy clinical PKU screening method. However, there is high false-positive rate associated with this modality, and its reduction can provide a diagnostic and economic benefit to both pediatric patients and health providers. Machine learning methods have the advantage of utilizing high-dimensional and complex features, which can be obtained from the patient's metabolic patterns and interrogated for clinically relevant knowledge. In this study, using TQ-MS screening data of more than 600,000 patients collected at the Newborn Screening Center of Shanghai Children's Hospital, we derived a dataset containing 256 PKU-suspected cases. We then developed a machine learning logistic regression analysis model with the aim to minimize false-positive rates in the results of the initial PKU test. The model attained a 95–100% sensitivity, the specificity was improved 53.14%, and positive predictive value increased from 19.14 to 32.16%. Our study shows that machine learning models may be used as a pediatric diagnosis aid tool to reduce the number of suspected cases and to help eliminate patient recall. Our study can serve as a future reference for the selection and evaluation of computational screening methods.